Cheng-hsien Hung

Taitung, TNQ 40201, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Comment on: "Impact of GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus on the Development and Progression of Age-Related Macular Degeneration".

Comment on: "Impact of GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus on the Development and Progression of Age-Related Macular Degeneration".

Journal: Retina (Philadelphia, Pa.)

Published: August 25, 2026

Letter: Calendar Era or Antiviral Choice-What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection?

Letter: Calendar Era or Antiviral Choice-What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection?

Journal: Alimentary pharmacology & therapeutics

Published: August 01, 2026

Editorial: Strategic Management of Osteoporosis: Integrating Sequential and Goal-Directed Treatment Approaches.

Editorial: Strategic Management of Osteoporosis: Integrating Sequential and Goal-Directed Treatment Approaches.

Journal: International journal of rheumatic diseases

Published: March 16, 2026

Comparative Effectiveness and Cardiovascular Safety of Romosozumab versus Teriparatide in Osteoporosis Patients with CKD: Target Trial Emulation Study.

Comparative Effectiveness and Cardiovascular Safety of Romosozumab versus Teriparatide in Osteoporosis Patients with CKD: Target Trial Emulation Study.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 16, 2026

Divergent Risks of Endocrine and Non-Endocrine Malignancies in GLP-1 Receptor Agonist Users: A Propensity-Matched Real-World Analysis of Over 140,000 Patients.

Divergent Risks of Endocrine and Non-Endocrine Malignancies in GLP-1 Receptor Agonist Users: A Propensity-Matched Real-World Analysis of Over 140,000 Patients.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: February 23, 2026

Real-world cardiovascular risk comparison of first-line osimertinib and earlier generation EGFR-TKIs in EGFR-mutated NSCLC: a TriNetX USA network analysis.

Real-world cardiovascular risk comparison of first-line osimertinib and earlier generation EGFR-TKIs in EGFR-mutated NSCLC: a TriNetX USA network analysis.

Journal: BMC cancer

Published: February 12, 2026

GLP-1 Receptor Agonists and Risk of Age-Related Macular Degeneration in Older Adults With Obesity: A Target Trial Emulation.

GLP-1 Receptor Agonists and Risk of Age-Related Macular Degeneration in Older Adults With Obesity: A Target Trial Emulation.

Journal: Diabetes, obesity & metabolism

Published: February 10, 2026

New Pathological Insights into Biomarkers for Multimodal Therapeutic Approach in Hepatic Neuroendocrine Tumors: A Detailed Case Report.

New Pathological Insights into Biomarkers for Multimodal Therapeutic Approach in Hepatic Neuroendocrine Tumors: A Detailed Case Report.

Journal: In vivo (Athens, Greece)

Published: January 09, 2026

Impact of the Mediterranean Diet on Glycemic Control, Body Mass Index, Lipid Profile, and Blood Pressure in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

Impact of the Mediterranean Diet on Glycemic Control, Body Mass Index, Lipid Profile, and Blood Pressure in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

Journal: Nutrients

Published: October 03, 2025

Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies.

Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: September 17, 2025

Beyond the Inflammation: Integrating Mental Health Into Rheumatic Disease Care.

Beyond the Inflammation: Integrating Mental Health Into Rheumatic Disease Care.

Journal: International journal of rheumatic diseases

Published: September 14, 2025

Janus Kinase Inhibitor-Induced Acne: An Indication-Specific Adverse Event of JAK1 Inhibition.

Janus Kinase Inhibitor-Induced Acne: An Indication-Specific Adverse Event of JAK1 Inhibition.

Journal: International journal of rheumatic diseases

Published: August 28, 2025

Showing 1-12 of 39

Last Updated: 09/26/2026